These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 20431558)
21. Do companion diagnostics make economic sense for drug developers? Agarwal A N Biotechnol; 2012 Sep; 29(6):695-708. PubMed ID: 22575210 [TBL] [Abstract][Full Text] [Related]
22. The biggest challenges currently facing companion diagnostic advancement. Halim AB Expert Rev Mol Diagn; 2014 Jan; 14(1):27-35. PubMed ID: 24308333 [TBL] [Abstract][Full Text] [Related]
23. Genetic testing in cancer therapeutics. Ezzeldin HH; Diasio RB Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783 [No Abstract] [Full Text] [Related]
24. Combat against cancer with science and medicine. Chow LW; Toi M Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S3-4. PubMed ID: 20374027 [No Abstract] [Full Text] [Related]
25. Update on pharmacogenetics in cancer chemotherapy. Innocenti F; Ratain MJ Eur J Cancer; 2002 Mar; 38(5):639-44. PubMed ID: 11916544 [TBL] [Abstract][Full Text] [Related]
26. From the lab to the clinic: integration of pharmacogenics into clinical development. Hoban CJ Pharmacogenomics; 2002 Jul; 3(4):429-36. PubMed ID: 12164766 [No Abstract] [Full Text] [Related]
27. Pharmacogenomics. Cancer sharpshooters rely on DNA tests for a better aim. Couzin J Science; 2004 Aug; 305(5688):1222-3. PubMed ID: 15333809 [No Abstract] [Full Text] [Related]
28. Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs. Tibau A; Díez-González L; Navarro B; Galán-Moya EM; Templeton AJ; Seruga B; Pandiella A; Amir E; Ocana A Mol Diagn Ther; 2017 Jun; 21(3):337-343. PubMed ID: 28247182 [TBL] [Abstract][Full Text] [Related]
36. Integrating molecular diagnostics into anticancer drug discovery. Peták I; Schwab R; Orfi L; Kopper L; Kéri G Nat Rev Drug Discov; 2010 Jul; 9(7):523-35. PubMed ID: 20531274 [TBL] [Abstract][Full Text] [Related]
37. The potential of circulating nucleic acids as components of companion diagnostics for predicting and monitoring chemotherapy response. Schwarzenbach H Expert Rev Mol Diagn; 2015 Feb; 15(2):267-75. PubMed ID: 25382372 [TBL] [Abstract][Full Text] [Related]